ALT on a Blood Test: What the Number Actually Means

ALT — alanine aminotransferase — is an enzyme concentrated in liver cells. When those cells are damaged, ALT leaks into the blood, which is why it appears on almost every routine panel as a liver marker. That much is standard.

What is less standard, and considerably more useful, is that two of the assumptions most people bring to an ALT result are questionable: that the lab’s “normal” range is meaningful, and that a low number is good news.

What does ALT measure?

ALT catalyses a step in amino-acid metabolism and sits at high concentration inside hepatocytes. Serum ALT is therefore an indirect measure of hepatocellular turnover — how much liver cell content is reaching the bloodstream. It is sensitive to liver injury but not specific to any one cause. Fatty liver, viral hepatitis, alcohol, medications, and muscle injury can all move it.

It is almost always read alongside AST, and the two together are more informative than either alone.

Why is the “normal” range different at every lab?

Because each laboratory derives its own reference range from its own local population, and those populations were not screened the way you would expect.

An analysis published in Archives of Internal Medicine compared eleven clinical laboratories and found upper reference limits ranging from 35 U/L to 79 U/L for men, and 31 U/L to 55 U/L for women. That is more than a twofold spread for the same enzyme, measured on comparable analysers.

The authors identified the cause, and it is not instrument variation. Laboratories built their reference ranges from cohorts that excluded known disease — but, in their words, “overweight and obesity were not taken into account by any of the laboratories.” Since obesity drives non-alcoholic fatty liver disease, and fatty liver raises ALT, the reference populations themselves contained a substantial amount of undiagnosed liver disease. That inflates the average, which inflates the upper limit, which makes genuinely abnormal results look normal.

The same paper cites a population study proposing a considerably tighter healthy range: up to 30 U/L for men and 19 U/L for women.

	Typical lab ULN	Proposed healthy range
Men	35–79 U/L	up to 30 U/L
Women	31–55 U/L	up to 19 U/L

A result flagged “normal” by a laboratory whose reference cohort included undiagnosed fatty liver is not the same as a result that is normal for a metabolically healthy person.

This is the practical takeaway for anyone tracking their own biomarkers: the flag on the report tells you where you sit relative to that lab’s population, not where you sit relative to health.

Does a low ALT mean a healthy liver?

Not necessarily, and this is where the marker gets genuinely interesting for anyone thinking about aging rather than about disease.

A nationwide cohort study published in PLoS One in 2020 followed 6,169 US adults and looked at ALT within the normal range — not elevated results. It found an inverse association with all-cause mortality. Men in the highest normal quartile (≥20 IU/L) had an adjusted hazard ratio of 0.56 (95% CI 0.42–0.74) compared with the lowest quartile (<12 IU/L). In women, the highest quartile (≥14 IU/L) versus the lowest (<9 IU/L) gave 0.55 (95% CI 0.40–0.77).

Higher ALT, within normal limits, tracked with lower death rates.

Why would a low ALT be a bad sign?

The authors’ explanation is mechanical rather than hepatic. Low ALT levels, they write, “may reflect decreased muscle mass or decreased blood flow to muscle cells,” and they note that decreased ALT in older age groups is associated with frailty and reduced muscle strength. Sarcopenia is itself a mortality risk factor.

So a very low ALT in an older adult may be reporting on skeletal muscle, not on the liver. That reframes the number: at the low end it behaves less like a liver marker and more like a proxy for how much muscle a person is carrying — which is why it appears alongside other markers in biological age scoring.

Two caveats belong here. The association was not U-shaped for all-cause mortality, but a U-shaped pattern did appear for cardiovascular mortality in women. And this is observational data: it establishes that low ALT travels with higher mortality, not that raising ALT would change anything.

How should you read your own result?

Read it in context rather than as a pass/fail flag.

An ALT above the proposed healthy thresholds — roughly 30 U/L for men, 19 U/L for women — deserves attention even when the lab has not flagged it, particularly alongside central adiposity or metabolic markers, since fatty liver is the most common driver in that range. The relationship between metabolic health and liver fat is why GLP-1 therapy has been studied in MASH.

A very low ALT is worth noticing rather than celebrating, especially past middle age, and is best interpreted next to measures of muscle mass and function.

And a single value is close to meaningless. ALT moves with recent alcohol, recent intense exercise, and medication. A trend across several draws says far more than one number, which is the general principle behind tracking biomarkers rather than reacting to them.

Frequently asked questions

What is a normal ALT level?

It depends entirely on which laboratory ran the test. Across eleven labs, upper limits ranged from 35 to 79 U/L for men and 31 to 55 U/L for women. A proposed healthy range — derived from cohorts screened for metabolic health — is up to 30 U/L for men and 19 U/L for women.

What does a high ALT mean?

That liver cells are releasing more enzyme than usual. It is sensitive but not specific: fatty liver, alcohol, viral hepatitis, medications, and muscle injury all raise it. A high ALT identifies that something is happening, not what.

Is low ALT good or bad?

Low is not automatically good. In a 6,169-adult cohort, the lowest normal quartile carried roughly twice the all-cause mortality of the highest, and the authors linked low ALT to reduced muscle mass and frailty in older adults. In an older person, a very low ALT is worth discussing rather than dismissing.

What is the difference between ALT and AST?

Both are aminotransferases released by damaged cells, but AST is present in heart and skeletal muscle as well as liver, so it is less liver-specific. The two are interpreted together, and their ratio carries information neither gives alone.

Does exercise affect ALT?

It can. Intense or unaccustomed exercise causes muscle enzyme release that raises both AST and, to a lesser degree, ALT. Testing several days after hard training avoids reading a muscle signal as a liver one.

The takeaway

ALT is a more interesting marker than its routine presentation suggests. The reference range printed beside your result was probably built from a population that included undiagnosed fatty liver, so “within normal limits” is a weaker reassurance than it reads as. And at the low end the enzyme appears to report on muscle rather than liver, which is why the lowest normal quartile carried the highest mortality in a large US cohort.

None of this is a basis for self-diagnosis, and none of it replaces a clinician reading your full panel alongside your history. It is a reason to read the number as a position on a distribution rather than as a verdict.